XRAY vs STAA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 20, 2026

XRAY

54.2
AI Score
VS
XRAY Wins

STAA

35.7
AI Score

Investment Advisor Scores

XRAY

54score
Recommendation
HOLD

STAA

36score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric XRAY STAA Winner
Forward P/E 6.3291 62.5 XRAY
PEG Ratio 0.633 0.7622 XRAY
Revenue Growth -4.1% 111.0% STAA
Earnings Growth 15.2% -10.5% XRAY
Tradestie Score 54.2/100 35.7/100 XRAY
Profit Margin -15.0% 1.1% STAA
Beta 1.00 1.00 Tie
AI Recommendation HOLD AVOID NEW MONEY XRAY

Relative Price Performance (Last 90 Days)

XRAY 1M: -2.9% · 3M: -26.5% STAA 1M: +13.6% · 3M: -3.8%

Current Technical Phase

XRAY

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 55

RSI (14): 55.1 · Price: $9.50

STAA

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 53

RSI (14): 52.6 · Price: $22.49

Fundamentals Snapshot

Metric XRAY STAA
Market Cap — —
Forward P/E 6.4 20.2
Trailing P/E — 270.1
Revenue (TTM) — —
Revenue Growth 0.0% 1.1%
Gross Margin 0.5% 0.8%
Operating Margin 0.1% 0.1%
EPS -2.73 0.08
Dividend Yield 0.04% —

Frequently Asked Questions

Based on our detailed analysis, XRAY is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.